Abstract: This invention provides compositions and methods to treat a condition or disease without the use of exogenous targeting sequences or chemical compositions. The present invention relates to single-domain antibodies (sdAbs), proteins and polypeptides comprising the sdAbs that are directed against intracellular components that cause a condition or disease. The invention also includes nucleic acids encoding the sdAbs, proteins and polypeptides, and compositions comprising the sdAbs. The invention includes the use of the compositions, sdAbs, and nucleic acids encoding the sdAbs for prophylactic, therapeutic or diagnostic purposes.

Abstract: Methods of treating disorders in which TNF? activity is detrimental via biweekly, subcutaneous administration of human antibodies, preferably recombinant human antibodies, that specifically bind to human tumor necrosis factor ? (hTNF?) are disclosed. The antibody may be administered with or without methotrexate. These antibodies have high affinity for hTNF? (e.g., Kd=10?8 M or less), a slow off rate for hTNF? dissociation (e.g., Koff=10?3 sec?1 or less) and neutralize hTNF? activity in vitro and in vivo. An antibody of the invention can be a full-length antibody or an antigen-binding portion thereof. Kits containing a pharmaceutical composition and instructions for dosing, and preloaded syringes containing pharmaceutical compositions are also encompassed by the invention.

Abstract: The present invention is directed to therapeutic methods using antibodies and fragments thereof having binding specificity for IL-6 to prevent or treat cachexia, fever, weakness and/or fatigue in a patient in need thereof. In preferred embodiments these patients will comprise those exhibiting (or at risk of developing) an elevated serum C-reactive protein level. In another preferred embodiment, the patient's survivability or quality of life will preferably be improved.

Abstract: Disclosed herein are humanized anti-LGR5 antibodies for the treatment of cancer. Antibodies disclosed herein may bind LGR5 without disrupting LGR5-RSPO1 binding or signaling, and may disrupt LGR5 signaling through Wnt that is independent of RSPO1. Also disclosed are heavy and light chain polypeptide sequences for the biding of LGR5, for example without disrupting LGR5-RSPO binding or signaling.

Abstract: The invention provides humanized anti-Siglec-8 antibodies and their use in treating and preventing eosinophil-mediated disorders and/or mast cell-mediated disorders, as well as compositions and kits comprising the humanized anti-Siglec-8 antibodies.

Abstract: The present disclosure provides isolated monoclonal antibodies, particularly human monoclonal antibodies that specifically bind to PD-L1 with high affinity. Nucleic acid molecules encoding the antibodies of this disclosure, expression vectors, host cells and methods for expressing the antibodies of this disclosure are also provided. Immunoconjugates, bispecific molecules and pharmaceutical compositions comprising the antibodies of the invention are also provided. The disclosure also provides methods for detecting PD-L1, as well as methods for treating various diseases, including cancer and infectious diseases, using anti-PD-L1 antibodies.

Abstract: Antibodies having a high specificity and high affinity towards the human gene product MUC1, which in specific variants is associated with neoplastic cells, i.e. tumor tissue, to the use of the antibodies for medical purposes, i.e. for tumor treatment, and for analytical purposes, e.g. for tumor diagnosis. Compositions comprising the antibodies, e.g. for use in the analytical processes and analysis, to pharmaceutical compositions comprising the antibodies, and to use of the antibodies in the manufacture of pharmaceutical compositions for tumor treatment or for diagnostic purposes.

Abstract: The present invention provides antibodies that bind to Tie2 and methods of using same. According to certain embodiments of the invention, the antibodies are fully human antibodies that bind to human Tie2 and block the interaction between Tie2 and one or more Tie2 ligands such as angiopoietin 1 (Ang1), angiopoietin 2 (Ang2), angiopoietin 3 (Ang3) and/or angiopoietin 4 (Ang4). The antibodies of the invention are useful, inter alia, for the treatment of diseases and disorders associated with one or more Tie2 biological activities including angiogenesis.

Abstract: Recombinant antibodies (including binding fragments thereof) that bind IgE are described, along with compositions and methods of using the same in the treatment of subjects in need thereof, including subjects afflicted with atopic dermatitis, allergic rhinitis, allergic conjunctivitis, urticaria, gastro-intestinal inflammation, or oral-pharyngeal inflammation. In some embodiments, the antibody is a single chain variable fragment (scFv) or a disulfide linked variable fragment (sdFv). In some embodiments, the subject is a dog, cat, or horse.

Abstract: Methods for preparing an antibody are provided with the method including incorporating 3-bromo-4-hydroxy-benzoic acid into a protein to form an antigen, immunizing a mammalian host with the antigen, and recovering an antibody having an affinity for the antigen from the host. Antibodies having a binding affinity for a monohalotyrosine are provided as well as composition comprising an antibody bound with monohalotyrosine. Compositions comprising a protein having a 3-bromo-4-hydroxy-benzoic acid moiety are also provided. Methods for evaluating the severity of asthma are provide with the methods including analyzing sputum of a patient using an antibody having a binding affinity for monohalotyrosine, and measuring the amount of antibody bound to protein.

Abstract: This invention relates to a fusion protein comprising the TMD of the transcription factor and PTD, an inhibitor for transcription factor function comprising the same, and a method for producing the same. Various diseases associated with malfunctions or defects of the transcription factor are effectively treated using the fusion protein according to the present invention.

Abstract: Provided is a method for producing low-substituted hydroxypropylcellulose in which depolymerization capable of achieving a target viscosity in a short time is carried out safely after an etherification reaction step. More specifically, provided is a method for producing low-substituted hydroxypropylcellulose having a degree of hydroxypropoxy substitution of from 9.5 to 16.0% by weight, comprising at least a step of reacting alkali cellulose with an etherifying agent and a step of carrying out depolymerization after the reaction.

Abstract: A process for dewatering biomass material comprising polysaccharide and water. The process comprises wetting the biomass material with a wetting composition comprising an alcohol to form a biomass slurry comprising wetted biomass material and a liquid component, mechanically separating a portion of the liquid component from the biomass slurry, and mechanically separating at least a portion of the water from the wetted biomass material. A process for extracting polysaccharide from the biomass material and a dewatered biomass material are also disclosed.

Abstract: Processes for recovering natural rubber from an aqueous natural rubber latex that contains extractables and one or more additives and that is essentially free of lignocellulosic plant material are described. Natural rubber in the latex is separated from the water. Preferably, the amount of non-rubber extractables in the natural rubber is reduced by one or more extraction steps yielding a dried natural rubber.

Abstract: A procedure for improved temperature control in controlled radical polymerization processes is disclosed. The procedure is directed at controlling the concentration of the persistent radical in ATRP and NMP polymerizations procedures and the concentration of radicals in a RAFT polymerization process by feeding a reducing agent or radical precursor continuously or intermittently to the reaction medium through one of more ports.

Abstract: Provided is a low-cost, highly active, environmentally friendly living radical polymerization catalyst which does not require a radical initiator. An organic compound having an oxidation-reduction capability is used as a catalyst. Even if a radical initiator is not used, a monomer can be subjected to a radical polymerization to obtain a polymer having narrow molecular weight distribution. The cost of the living radical polymerization can be remarkably reduced. It is made possible to prevent adverse effects of using a radical initiator. The present invention is significantly more environmentally friendly and economically excellent than conventional living radical polymerization methods, due to advantages of the catalyst such as low toxicity of the catalyst, low amount of the catalyst necessary, high solubility of the catalyst, mild reaction conditions, and no coloration/no odor (which do not require a post-treatment for a molded article), etc.

Abstract: A process for preparing a polydiene, the process comprising the steps of (i) providing conjugated diene monomer; (ii) charging a nickel-based catalyst system to the conjugated diene monomer; and (iii) charging a modulating Lewis base to the conjugated diene monomer, to thereby polymerize the conjugated diene monomer in the presence of the modulating Lewis base, where said step of charging a modulating Lewis base is separate from said step of charging a nickel-based catalyst, and where said steps of providing conjugated diene monomer, charging a nickel-based catalyst system and charging a Lewis base form a polymerization mixture that includes less than 20% by weight of organic solvent based on the total weight of the polymerization mixture.

Abstract: The present invention provides polymers resulting from modification of polymeric moieties containing an anhydride with modifying reactant moieties. The invention further provides a wide variety of compositions comprising the and modified polymeric moieties containing an anhydride. The letters b, d, e, and z are described herein.

Abstract: Methods for synthesizing a random copolymer having a phosphorylcholine group. Syntheses involving a reaction mixture containing a chain transfer agent (CTA), a solvent, a hydrophobic methacrylate monomer, a 2-methacryloyloxyethyl phosphorylcholine (MPC) monomer, and, optionally, an initiator. The random copolymers produced by such synthesis methods having a polydispersity index (PDI) of less than about 1.3 and a peak molecular weight (Mp) of less than about 130,000. Polymer blends and medical devices including such random copolymers, and methods of treating a mammal using such random copolymers or medical devices.

Abstract: The present invention provides a method of producing a polyolefin composition comprising contacting a binuclear metallocene pre-catalyst and a co-catalyst, adding a excess of a metal alkyl, then adding a first olefin monomer. The method allows for the production of polyolefins with a highly stereoregular stereochemical microstructure through living coordination polymerization in which rapid reversible chain transfer between a racemic mixture of a chiral active transition metal propagating center and multiple equivalents of inert main group metal alkyl is competitive with chain-growth propagation at the active center.

Abstract: In accordance with the present disclosure there is provided a process for preparing a hydrogenated olefin polymer by hydrogenation of a polyoctene; said polyoctene being prepared by reacting a C8-olefin feed comprising an isomeric mixture of an alpha-olefin and a non-alpha olefin monomer in a controlled manner with the help of an ionic catalyst, while controlling at least one condition of the reaction selected from the group of condition consisting of exotherm, contact time of the olefin feed with ionic catalyst and molar ratio of the ionic catalyst to the olefin feed within predetermined ranges to obtain an oligomerized mixture comprising at least one polyoctene and unreacted ionic catalyst.

Abstract: The invention provides a rubber composition prepared by mixing, per 100 parts by mass of the rubber component comprising at least 50% by mass of a diene-based rubber, from 20 to 150 parts by mass of a filler, and from 0.05 to 30 parts by mass of a compound A which has a specific amidine structure and has a functional group reactive with the diene-based rubber. The rubber composition improves both a high elastic modulus and a low tan ?. The invention also provides a pneumatic tire using the rubber composition.

Abstract: A metal complex of the formula (1) CyAMX(L)n??(1) wherein Cy is a cyclopentadienyl-type ligand, M is a metal of group 4; A is an amidine-containing ligand moiety, represented by formula 2: wherein the amidine-containing ligand is covalently bonded to the metal M via the imine nitrogen atom, and Sub1 is a substituent comprising a group 14 atom through which Sub1 is bonded to the imine carbon atom and Sub2 is a substituent comprising a heteroatom of group 15, through which Sub2 is bonded to the imine carbon atom; X is an allyl borate ligand derived from a conjugated diene ligand, D, and a borane, B and L is a neutral Lewis basic ligand wherein the number of said metal ligands “n” is in the range of 1 to the amount that specifies the 18-electron rule.

Abstract: A metal fine particle dispersant is obtained by reaction of a polymer (a) containing a first reactive functional group, an ionic group to be absorbed to metal fine particles, and a polyoxyalkylene side chain with a compound (b) containing a second reactive functional group to be bonded to the first reactive functional group and an active energy ray curable group to be cured by an active energy ray. A metal fine particle dispersion liquid containing the metal fine particle dispersant, metal fine particles, and a dispersion medium is prepared. The metal fine particle dispersion liquid is cured, thereby obtaining a cured film.

Abstract: The present invention relates to polymers, especially polymers useful as hydrogels, and to use of hydrogels for repair or restoration of tissue. In particular, the polymers and hydrogels of the present invention can be used for the repair or restoration of cartilage, especially articular cartilage. The polymers comprise at least a monomer for binding water, a monomer for imparting mechanical properties and a monomer for binding to an extracellular protein. The hydrogels comprise a polymer comprising at least a monomer for binding water and a monomer for binding to an extracellular protein. Crosslinking polymers by binding of said extra-cellular matrix protein forms hydrogels.

Abstract: Biodegradable, cross-linked polymer particle embolics and methods of making the same are described. The particle embolics can be used as embolization agents.

Abstract: A process for treating a polymer having a hydrolyzable functionality, the process comprising: (i.) providing a polymer having hydrolyzable functionality; (ii.) introducing an alkoxysilane to the polymer, where the alkoxysilane is defined by the formula I ?where R2 is a hydrocarbyl group, R3, R4, and R5 are each independently a hydrocarbyl group or a hydrocarbyloxy group; and (iii.) introducing a silane having a hydrolyzable functionality, where the silane is defined by the formula II where ? is a hydrolyzable group that forms an acidic species upon hydrolysis, where R6, R7, and R8 are each independently a halogen atom, a hydrocarbyl group, a hydrocarboxylate group, or a hydrocarbyloxy group.

Abstract: The present invention relates to a method for producing a hydrogenated conjugated diene copolymer including a polymerization step and a hydrogenation step, wherein in the polymerization step, a conjugated diene copolymer having a high vinyl bond amount of a conjugated diene block moiety and a narrow molecular weight distribution can be produced, and in the hydrogenation step, the rate of hydrogenation is high and productivity is excellent.

Abstract: Provided is a carboxy-modified synthetic isoprene polymer latex for dip molding use, which is produced by the graft polymerization of a synthetic isoprene polymer with a monomer having a carboxyl group in an aqueous phase and contains at least one anionic surfactant, wherein a carboxy-modified synthetic isoprene polymer that constitutes the carboxy-modified synthetic isoprene polymer latex has a tetrahydrofuran-insoluble content of 30 wt % or more.

Abstract: The present invention is related to a method for producing a polymer to efficiently remove metal residues of at least lithium and/or titanium from a polymer solution comprising the at least lithium and/or titanium to thereby obtain a refined polymer solution having little metal residue.

Abstract: A high-quality polyacetal copolymer produced by a simple process in an economical manner. The process includes supplying a raw material including trioxane and the like to a reaction device; setting the polymerization environmental temperature to no more than 100° C. until the reaction device conversion rate becomes 0.5, and then carrying out further polymerization; vaporizing and separating unreacted monomers from the reaction mixture at an environmental temperature of at least 115° C. and less than 140° C.; supplying the separated monomers to the raw material supply; and recovering the polyacetal copolymer from the reaction mixture.

Abstract: The present invention relates to novel thermoplastic polyurethane (TPU) compositions that have crystalline chain ends. The TPU compositions of the invention can provide improved resiliency, lower surface free energy, and/or reduced stickiness, while maintaining other desirable physical properties. The present invention also provides the described TPU compositions that are further grafted with vinyl alkoxysilane moieties allowing for crosslinked networks of the TPU compositions. The present invention also provides plasticizer-free, very soft TPU compositions without the processing difficulties often associated with such materials. The invention further provides means of reducing the surface tension of a TPU composition which can allow for improved blend compositions, and means of crosslinking the described TPU compositions.

Abstract: The disclosure relates to solving problems associated with conventional latent epoxy curing agents by providing a new class of latent epoxy curing agents. In particular, the disclosure relates to epoxy curing agents with improved storage stability and low use level (e.g., less than about 10 wt % relative to the epoxy compound) by forming solid solutions of certain classes of amines in polyphenolic resins.

Abstract: Disclosed herein are processes for preparing articles from compositions including a cross-linked polycarbonate. The cross-linked polycarbonate may be derived from a polycarbonate having about 0.5 mol % to about 5 mol % endcap groups derived from a monohydroxybenzophenone. The article is molded, then exposed to UV radiation. A plaque including the composition can achieve a UL94 5VA rating.

Abstract: This invention provides a chlorinated poly(propylene carbonate) and the preparation method thereof, the chlorinated poly(propylene carbonate) is as represented by formula (I). Compared to the prior poly(propylene carbonate)s, the chlorinated poly(propylene carbonate) has relatively stronger electronegativity due to the presence of chlorine atoms and the interaction of the chlorinated poly(propylene carbonate) with other polar materials can be enhanced, so that it can be widely used as a compatilizer, a binder, a paint, an ink, and the like. After the introduction of chlorine atoms, hydrogen bond interaction is generated within the chlorinated poly(propylene carbonate), so that its processability and mechanical properties are both improved. Furthermore, the chlorine atom may improve the flame retardancy of chlorinated poly(propylene carbonate) materials.

Abstract: Polymer complex obtained by polymerization of water-soluble monomers: in the presence of a host polymer comprising vinylamine functions and of a non-polymeric transfer agent, and in the absence of branching or crosslinking agent of ethylenic polyfunctional type.

Abstract: Explosives detection polymers are provided that include a polyamine polymer, such as polyethylenimine, functionalized with a small molecule fluorophore. Methods for detecting an explosive material using polyamine polymers functionalized with a small molecule fluorophore are also provided. Sensors for explosive detection are provided that include a polyamine polymer functionalized with a small molecule fluorophore and a complementary analytical device.

Abstract: The present invention relates to polyarylene sulfide, in which a ratio of a peak area of a polymer chain of a second polyarylene sulfide having a lower molecular weight than the maximum peak molecular weight to a peak area of a polymer chain of a first polyarylene sulfide having a higher molecular weight than the maximum peak molecular weight is 1.3 or less in the molecular weight distribution of the polyarylene sulfide, as measured by gel permeation chromatography using polystyrene as a standard, and a preparation method thereof. This polyarylene sulfide exhibits excellent processability and generates no burrs (flashes) or the like, and can satisfactorily mold a product requiring high molding precision.

Abstract: The present invention is to provide a process for preparing a highly polymerized aromatic polycarbonate resin, which comprises the steps of a highly polymerizing step for reacting an aromatic polycarbonate prepolymer and an aliphatic diol compound in the presence of a transesterification catalyst to obtain a highly polymerized aromatic polycarbonate resin, a cyclic carbonate removal step for removing at least part of the cyclic carbonate by-produced in the above highly polymerizing step out of the reaction system, and a recycle step of hydrolyzing the cyclic carbonate removed in the cyclic carbonate removal step to obtain an aliphatic diol compound and using the obtained aliphatic diol compound as at least a part of the aliphatic diol compound to be used in the highly polymerizing step.

Abstract: This invention relates to the preparation of a dynamically vulcanized alloy comprising at least one elastomer and at least one thermoplastic resin. More specifically, the process produces dynamically vulcanized alloys with unique morphological features which have good impermeability and low temperature flexibility. In the process, the thermoplastic resin is added into the extruder in two stages with an intermediate addition of a compatibilizer. Also during the final addition of thermoplastic resin, the elastomeric curatives are added to the extruder.

Abstract: This invention relates to the preparation of a dynamically vulcanized alloy comprising at least one elastomer and at least one thermoplastic resin, having a G? at 1% strain and 100° C. as determined according to ASTM D7605 of about 4,500 to about 7,500 kPa. More specifically, the process produces dynamically vulcanized alloys with unique morphological features which have good impermeability and low temperature flexibility. In the process, the thermoplastic resin is added into the extruder in two stages with an intermediate addition of a compatibilizer. Also during the final addition of thermoplastic resin, the elastomeric curatives are added to the extruder.

Abstract: The invention relates to the use of at least one mixed mineral organoclay rheology additive, which comprises or consists of a quaternary alkyl-ammonium salt treated mineral clay mixture prepared by forming an aqueous hormite clay slurry (a), forming an aqueous smectite clay slurry (b), combining the aqueous hormite clay slurry (a) with the aqueous smectite clay slurry (b) to form a combined clay slurry (c), treating the combined clay slurry (c) with one or more quaternary alkyl-ammonium salts, separating the thus produced quaternary alkyl-ammonium salt treated mineral clay mixture from the aqueous medium, in which the aqueous hormite clay slurry (a) being formed by (i.1) dispersing a fraction of one or more hormite clays selected from the group of sepiolites and palygorskites in an aqueous medium to form a dispersion, and the aqueous smectite clay slurry (b) being formed by (ii.

Abstract: The present invention relates to a method for producing a polyolefin porous film, the method including the steps of: (a) melt-kneading a solution containing a polyolefin having a weight average molecular weight of 500,000 or more and a solvent to obtain a kneaded product; (b) extruding and cooling the kneaded product to obtain a gel-like molded product; (c) drawing the gel-like molded product to obtain a drawn sheet; (d) removing the solvent from the drawn sheet, followed by drying to obtain a film in which fine pores are formed; (e) conducting heat treatment, while fixing the film in both directions of a MD and a TD thereof and drawing the film at a draw ratio of exceeding 0% to less than 0.1% in at least one direction of the MD and the TD thereof; and (f) conducting heat treatment while decreasing a width of the film in at least one direction of the MD and the TD of the film.

Abstract: The invention relates to the use of a composition comprising linear low density polyethylene and an inorganic acid in health care applications. The inorganic acid may be selected from the group consisting of aluminum oxide, zinc oxide, calcium oxide, calcium hydroxide, magnesium oxide, magnesium hydroxide, hydrotalcites and any mixtures of any one of these inorganic acids. Furthermore, the composition may further comprise low density polyethylene, for example in a weight ratio of 10/90 to 50/50 with linear low density polyethylene.

Abstract: To obtain a decorative film for insert molding, which is decorated by an ultraviolet curing ink-jet ink, and which exhibits excellent flexibility upon insert molding. A decorative film for insert molding, having on a film substrate a decorative layer formed from an ultraviolet curing ink-jet ink, wherein the elongation of the decorative film for insert molding is 150% or more under conditions at 180° C. and 50% or more under conditions at 25° C.

Abstract: A polymeric foam article with a polymer matrix defining multiple cells therein has a polymer component with a first polymer that is a polyhedral oligomeric silsesquioxane grafted polymer that has a weight-average molecular weight of two kilograms per mole or higher and 200 kilograms per mole or lower.

Abstract: The present invention provides porous carbon-heteroatom-silicon inorganic/organic homogenous copolymeric hybrid materials, methods for their preparation, and uses thereof, e.g., as chromatographic separations materials.

Abstract: The present invention relates generally to utilizing gasses for fragmenting polymeric materials and simultaneously modifying the surface area molecular structure of the said polymeric materials. More particularly, the present invention relates to a method and associated device for the processing of already preliminarily deformed polymeric materials, preferably without metal reinforcing elements, by utilizing aggressive gasses to both modify the polymeric materials surface area into an activated state and also simultaneously fragment the fed preliminarily deformed polymeric materials into a powder-like form with a relatively increased surface area.

Abstract: Triglyceride and other polyol ester PVC plasticizers can be produced by recovery of branched C6 to C9 aldehydes from a hydroformylation product, optional hydrogenation to the alcohol, oxidation to the acid with oxygen and/or air, recovery of the resulting acid, and esterification with glycerol, ethylene glycol, propylene glycol or mixtures thereof. The branched alkyl chains comprise at least 10% methyl branching. Special triglycerides are derived from branched aliphatic acids having alkyl chains with average carbon numbers from 6 to 9 and at least 10% methyl branching. These triglycerides are fast fusing plasticizers if before esterification with glycerol, an aryl acid is introduced together with the aliphatic acids.

Abstract: The present disclosure relates to a curable system comprising at least two compositions (A) and (B) where composition (A) comprises an epoxy resin, an inorganic thixotropic agent, an organic gelling agent and a filler and composition (B) comprises a hardener, an inorganic thixotropic agent, an organic thixotropic agent and filler. The curable system may be used in the manufacture of components or parts of electrical equipment.